“Comparison of Interpretation between Pyrosequencing and Xpert MTB/RIF Assay in Multidrug-Resistant Tuberculosis”, MKB, vol. 52, no. 4, pp. 238–242, Dec. 2020, doi: 10.15395/mkb.v52n4.2141.